92,841 research outputs found
Gordon B. Mills, MD, PhD, Oral History Interview, May 23, 2016
No full textMajor Topics Covered: Personal background; educational path Professional path prior to MD Anderson Research areas: immunology, targeted therapy, interleukin-2, Women’s Cancer Moon Shot Institutional development: Department of Systems Biology, Kleberg Institute, Zayed Institutehttps://openworks.mdanderson.org/mchv_interviewsessions/1011/thumbnail.jp
Chapter 14: MD Anderson Publications and Publication Ethics
No full textDr. Goepfert has served on a number of editorial boards and is keenly interested in the educational dissemination of information critical to cancer research. In this section he talks about some of MD Anderson’s publications and also addresses some controversies with publication. He first raises the ethical issue of how authorship is assigned to a manuscript going out for publication. Today there are guidelines for assigning authorship, but twenty years ago, he explains, some department chairs at MD Anderson reviewed all manuscripts going for publication and insisted on being listed as first author of an article, whether they made any contribution to the research or not. Dr. Goepfert contrasts his own practice of putting his name on a paper only if he has contributed. Dr. Goepfert then shifts subjects and describes several MD Anderson educational publications, beginning with Cancer Bulletin, distributed free to all physicians across Texas.https://openworks.mdanderson.org/mchv_interviewchapters/2010/thumbnail.jp
Chapter 06: Recruited to MD Anderson; A History of Translational Research at MD Anderson
No full textDr. Mills first tells how he was recruited to MD Anderson by Robert Bast, MD, VP of Translational Research, to set up the best ovarian research center. He explains why he left Toronto Hospital and cites the fact that no other institution has more potential to make a difference. Next, Dr. Mills sketches the history of translational research at MD Anderson. He begins with the 1970s, noting that the patient driven clinical research at that time was not real team science. He talks about the context for research under Charles LeMaistre and the VP of Research, Frederick Becker [oral history interview] and the vestiges of their approach still lingering. He explains that the institution has now embraced the concept that research is a driver in patient outcomes. Dr. Mills explains that leaders need to function as change agents and set in place processes that allow the success of research. He then compares the approach of John Mendelsohn, who allowed institutional change to be driven from the bottom up, with Ronald DePinho, who has taken the opposite approach as he framed the question, Is research progress an engineering and implementation question or do we lack the basic research to make progress at this time.https://openworks.mdanderson.org/mchv_interviewchapters/1064/thumbnail.jp
Chapter 10: MD Anderson Head & Neck Surgery Advances with Dental Oncology, Plastic Surgery and Neurosurgery
No full textDr. Byers talks about the role of dental oncology under Dr. Joe B. Drane, Head of UT Dental Branch/Dental Oncology, and the work done by Drs. James (Jim) C. Lemon and Jack W. Martin in managing dental problems with radiotherapy patients and fabrication of dental prostheses (ears, noses, dentures, swallowing apparatus). He then discusses the “free flap” plastic surgical method, and ENT/plastic surgery doctors Stephen S. Kroll, Mark A. Schusterman, Geoffrey L. Robb and David L. Larson who performed the surgery. Finally he mentions the role of neurosurgery, praises Neurosurgical Drs. Milam Leavens and Ray Sawaya, and finally discusses the Head & Neck department’s prominence in terms of MD Anderson case admission volume.https://openworks.mdanderson.org/surgeryhist_interviewchapters/1020/thumbnail.jp
Newsletter, Volume 23, Number 05, September - October 1978
No full textDr LeMaistre Assumes Presidency Hypopituitarism After Irradiation, Naguib A. Samaan, MD, PhD Dear Texas Physician, Dr. Charles A LeMaistre, MD To Refer a Patient CIS Adds Bilingual Program Nurses Receive B&PW Funds Respiratory Failure in Cancer Patients, M. Khalil Ali, MD, PhD In Memoriam: Olga Keith Wiess Cancer Rehabilitation and the Medical Oncologist, Charles K. Tashima, MDhttps://openworks.mdanderson.org/newsletter/1091/thumbnail.jp
Measurement of the B0–B0 oscillation frequency Δmd with the decays B0→D−π+ and B0→ J/ψK∗0
No full textThe B
0
–B
0
oscillation frequency Δmd is measured by the LHCb experiment using a dataset corresponding
to an integrated luminosity of 1.0 fb−1
of proton–proton collisions at √
s = 7 TeV, and is found to be
Δmd
=0.5156±0.0051 (stat.)±0.0033 (syst.) ps−1
. The measurement is based on results from analyses
of the decays B
0
→ D
−π
+ (D
−
→ K
+π
−π
−) and B
0
→ J/ψK
∗0
(J/ψ →μ
+μ
−,K
∗0
→ K
+π
−) and
their charge conjugated modes
OncoLog Volume 51, Number 04, April 2006
No full textRedefining Unresectable Disease: Strategies for Treating Liver Metastases from Colorectal Cancer Cancer Screening Guidelines Revised: One on One with Dr. Therese Bevers House Call; What Is Breast Self-Awareness ? DiaLog: The Revolutionary Cervical Cancer Vaccine, by Therese B. Bevers, MD, Medical Director, Cancer Prevention Centerhttps://openworks.mdanderson.org/oncolog/1180/thumbnail.jp
Wits Architecture Student Works 1922-1980; Lennard MD 1947 B Arch V. A Furniture Factory Sketch Design; Proposed Guest House, Lakeside View, Stand no 274, Northmere, B Arch II first term, 1947
No full textWits Architecture Student Works 1922-1980; Lennard, MD 1947-1950; Furniture Factory; Proposed Guest House LakesideViewWits Architecture Student Works 1922-1980; Lennard, MD 1947-1950; Furniture Factory; Proposed Guest House LakesideVie
OncoLog, Volume 45, Number 05, May 2000
No full textEarly Detection of Melanoma Spread May Increase Survival Benefits of Adjuvant Therapy No Easy Answers: Women at Increased Risk for Breast Cancer Face Difficult Choices DiaLog: Understanding Risk: A Prerequisite for Making Informed Decisions, by Gordon B. Mills, MD, PhD, Chairman, Department of Molecular Therapeutics House Call: Looking for Trouble: How to Spot Signs of Melanoma Protocols: Melanoma Clinical Trials Biochemotherapy Means Hope for Patients with Advanced Melanomahttps://openworks.mdanderson.org/oncolog/1085/thumbnail.jp
Gordon B. Mills, MD, PhD, Oral History Interview, September 1, 2016
No full textMajor Topics Covered: Research areas: immunology, targeted therapy, interleukin-2, Women’s Cancer Moon Shot Institutional development: Department of Systems Biology, Kleberg Institute, Zayed Institute Leadership and contributions in a collaborative contexthttps://openworks.mdanderson.org/mchv_interviewsessions/1012/thumbnail.jp
- …
